Skip to main content

Compare Stocks

Date Range: 

 StereotaxisZynexViewRayCuteraTransMedics Group
SymbolNYSEAMERICAN:STXSNASDAQ:ZYXINASDAQ:VRAYNASDAQ:CUTRNASDAQ:TMDX
Price Information
Current Price$6.85$13.87$5.18$29.81$22.24
52 Week RangeBuyBuyBuyBuyBuy
MarketRank™
Overall Score0.81.81.31.51.6
Analysis Score2.53.31.42.53.3
Community Score0.02.52.82.62.3
Dividend Score0.00.00.00.00.0
Ownership Score0.80.81.71.71.7
Earnings & Valuation Score0.62.50.60.60.6
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$8.00$21.63$4.86$33.00$43.60
% Upside from Price Target16.79% upside55.91% upside-6.23% downside10.70% upside96.04% upside
Trade Information
Market Cap$507.45 million$483.33 million$837.81 million$530.71 million$614.36 million
Beta1.560.60.641.62.16
Average Volume362,273542,2281,858,778214,975744,137
Sales & Book Value
Annual Revenue$28.90 million$45.47 million$87.78 million$181.71 million$23.60 million
Price / Sales17.5610.639.542.9226.03
CashflowN/A$0.31 per shareN/AN/AN/A
Price / CashN/A44.38N/AN/AN/A
Book Value$0.34 per share$0.60 per share$1.47 per share$3.23 per share$2.58 per share
Price / Book20.1523.123.529.238.62
Profitability
Net Income$-4,590,000.00$9.49 million$-120,200,000.00$-12,350,000.00$-33,550,000.00
EPS($0.10)$0.28($1.18)($0.88)($2.36)
Trailing P/E RatioN/A42.03N/AN/AN/A
Forward P/E RatioN/A26.67N/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-24.54%18.08%-166.74%-18.83%-131.35%
Return on Equity (ROE)-22.78%50.67%-63.41%-61.21%-38.95%
Return on Assets (ROA)-13.15%35.56%-36.34%-25.31%-24.10%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.05%0.01%0.26%0.14%0.32%
Current Ratio4.01%4.96%3.90%2.13%11.31%
Quick Ratio3.79%4.17%3.19%1.48%10.36%
Ownership Information
Institutional Ownership Percentage54.34%29.57%83.03%87.79%76.68%
Insider Ownership Percentage34.91%50.54%15.48%2.30%13.10%
Miscellaneous
Employees120768236323110
Shares Outstanding74.08 million34.85 million161.74 million17.80 million27.62 million
Next Earnings Date8/5/2021 (Estimated)7/26/2021 (Estimated)7/29/2021 (Estimated)8/5/2021 (Estimated)8/4/2021 (Estimated)
OptionableOptionableOptionableOptionableOptionableNot Optionable
SourceHeadline
TransMedics Group (NASDAQ:TMDX) Shares Gap Down on Analyst DowngradeTransMedics Group (NASDAQ:TMDX) Shares Gap Down on Analyst Downgrade
americanbankingnews.com - May 11 at 10:19 AM
Morgan Stanley Trims TransMedics Group (NASDAQ:TMDX) Target Price to $35.00Morgan Stanley Trims TransMedics Group (NASDAQ:TMDX) Target Price to $35.00
americanbankingnews.com - May 11 at 9:42 AM
TransMedics Group, Inc. (NASDAQ:TMDX) Given Consensus Recommendation of "Buy" by AnalystsTransMedics Group, Inc. (NASDAQ:TMDX) Given Consensus Recommendation of "Buy" by Analysts
americanbankingnews.com - May 10 at 7:36 AM
Earnings Update: TransMedics Group, Inc. (NASDAQ:TMDX) Just Reported And Analysts Are Trimming Their ForecastsEarnings Update: TransMedics Group, Inc. (NASDAQ:TMDX) Just Reported And Analysts Are Trimming Their Forecasts
nasdaq.com - May 7 at 8:24 PM
TransMedics Group (NASDAQ:TMDX) Shares Up 8.7%TransMedics Group (NASDAQ:TMDX) Shares Up 8.7%
americanbankingnews.com - May 7 at 2:04 PM
Brokers Issue Forecasts for TransMedics Group, Inc.s Q2 2021 Earnings (NASDAQ:TMDX)Brokers Issue Forecasts for TransMedics Group, Inc.'s Q2 2021 Earnings (NASDAQ:TMDX)
americanbankingnews.com - May 7 at 10:24 AM
Transmedics Group, Inc. (TMDX) CEO Waleed Hassanein on Q1 2021 Results - Earnings Call TranscriptTransmedics Group, Inc. (TMDX) CEO Waleed Hassanein on Q1 2021 Results - Earnings Call Transcript
seekingalpha.com - May 6 at 2:44 PM
TransMedics Group Inc. [TMDX] Stock trading around $24.96 per share: What’s Next?TransMedics Group Inc. [TMDX] Stock trading around $24.96 per share: What’s Next?
dbtnews.com - May 6 at 2:44 PM
Insider Selling: TransMedics Group, Inc. (NASDAQ:TMDX) VP Sells 1,680 Shares of StockInsider Selling: TransMedics Group, Inc. (NASDAQ:TMDX) VP Sells 1,680 Shares of Stock
americanbankingnews.com - May 5 at 11:08 PM
TransMedics Group (NASDAQ:TMDX) Releases Earnings Results, Misses Expectations By $0.01 EPSTransMedics Group (NASDAQ:TMDX) Releases Earnings Results, Misses Expectations By $0.01 EPS
americanbankingnews.com - May 5 at 3:14 PM
TransMedics Group (NASDAQ:TMDX) Price Target Cut to $35.00TransMedics Group (NASDAQ:TMDX) Price Target Cut to $35.00
americanbankingnews.com - May 5 at 12:12 PM
TransMedics Group (NASDAQ:TMDX) Shares Gap Down Following Weak EarningsTransMedics Group (NASDAQ:TMDX) Shares Gap Down Following Weak Earnings
americanbankingnews.com - May 5 at 11:13 AM
TransMedics: Q1 Earnings SnapshotTransMedics: Q1 Earnings Snapshot
sfgate.com - May 4 at 10:36 PM
TransMedics (TMDX) Reports Q1 Loss, Tops Revenue EstimatesTransMedics (TMDX) Reports Q1 Loss, Tops Revenue Estimates
finance.yahoo.com - May 4 at 10:36 PM
TransMedics Group (TMDX) Set to Announce Quarterly Earnings on TuesdayTransMedics Group (TMDX) Set to Announce Quarterly Earnings on Tuesday
americanbankingnews.com - May 3 at 6:36 AM
TransMedics Group, Inc. (NASDAQ:TMDX)’s -0.24% Fall This Week Just Tells Us Something NewTransMedics Group, Inc. (NASDAQ:TMDX)’s -0.24% Fall This Week Just Tells Us Something New
marketingsentinel.com - May 1 at 7:34 PM
TransMedics Group Inc (TMDX)TransMedics Group Inc (TMDX)
investing.com - April 30 at 1:50 PM
TransMedics Group (TMDX) to Release Quarterly Earnings on TuesdayTransMedics Group (TMDX) to Release Quarterly Earnings on Tuesday
americanbankingnews.com - April 27 at 8:50 AM
TransMedics Group (NASDAQ:TMDX) Shares Gap Up to $28.36TransMedics Group (NASDAQ:TMDX) Shares Gap Up to $28.36
americanbankingnews.com - April 22 at 11:36 AM
1 Feel-Good Healthcare Stock That Could Turn Your Tax Return Into Riches1 Feel-Good Healthcare Stock That Could Turn Your Tax Return Into Riches
finance.yahoo.com - April 22 at 10:18 AM
Stock Alert: TransMedics Group Up 11%Stock Alert: TransMedics Group Up 11%
markets.businessinsider.com - April 21 at 1:33 PM
TransMedics Group (NASDAQ:TMDX) Shares Up 4.6%TransMedics Group (NASDAQ:TMDX) Shares Up 4.6%
americanbankingnews.com - April 21 at 11:43 AM
TransMedics to Report First Quarter 2021 Financial Results on May 4, 2021TransMedics to Report First Quarter 2021 Financial Results on May 4, 2021
finance.yahoo.com - April 20 at 7:38 PM
What do Wall Street analysts think about TransMedics Group, Inc. (NASDAQ:TMDX) stock?What do Wall Street analysts think about TransMedics Group, Inc. (NASDAQ:TMDX) stock?
stocksregister.com - April 18 at 12:12 PM
TransMedics Groups Charts Are Pointed LowerTransMedics Group's Charts Are Pointed Lower
finance.yahoo.com - April 15 at 10:12 AM
DateCompanyBrokerageAction
12/30/2020StereotaxisNorthland SecuritiesReiterated Rating
6/22/2020StereotaxisLake Street CapitalBoost Price Target
4/19/2020StereotaxisCowenInitiated Coverage
2/26/2021ZynexB. RileyDowngrade
1/29/2021ZynexPiper SandlerDowngrade
9/14/2020ZynexHC WainwrightUpgrade
5/13/2021ViewRayGuggenheimUpgrade
4/1/2021ViewRayBTIG ResearchUpgrade
1/6/2021ViewRayMorgan StanleyBoost Price Target
6/23/2020ViewRayOppenheimerReiterated Rating
6/15/2020ViewRayCantor FitzgeraldInitiated Coverage
3/13/2020ViewRayMizuhoReiterated Rating
9/14/2020CuteraStephensBoost Price Target
5/8/2020CuteraMaxim GroupReiterated Rating
5/5/2020CuteraStifel NicolausUpgrade
8/22/2019CuteraSidotiDowngrade
3/15/2021TransMedics GroupCanaccord GenuityBoost Price Target
10/8/2020TransMedics GroupJPMorgan Chase & Co.Downgrade
(Data available from 5/16/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
Comparison Ideas:

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.